Blixt to pay £22m for first two acquisitions as it builds national practice


Harring: Ultimate owner

The private equity house looking to building a £100m group over the coming years is set to spend nearly £18m on its most recent acquisition, Lancashire law firm Farleys, it has emerged.

According to the annual accounts of Lawfront Holdings Ltd, Blixt’s legal business, this is split into an £11.4m upfront payment and contingent consideration of up to £6.3m.

Farleys’ most recent accounts, for the year to 31 March 2022, showed income up 17% to £12.2m, with profits of £6.2m to share between the partners.

The deal, which was announced last October, saw Farleys continue to operate under its own brand from six offices in the North-West. It has a broad private client and commercial practice, with 15 partners among 150 staff.

Blixt entered the legal market is summer 2021 by acquiring Essex law firm Fisher Jones Greenwood (FJG) and the Lawfront accounts indicate that it paid £2.9m in cash plus £1.2m in deferred consideration.

Lawfront says it is looking to build “a leading national law firm through partnering with high quality, likeminded firms concentrating on private clients and services to small and medium-sized businesses”.

It supports firms to develop their businesses “through investing capital and resources in central services, systems and, most importantly, people and culture”.

Blixt showed its willingness to support its firms last year when FJG acquired Essex and Suffolk firm Steed & Steed.

At the time, FJG managing partner Paula Cameron explained that Blixt aimed to create six or seven more regional “hubs” across England and Wales.

Lawfront’s chief executive is Neil Lloyd, who recently joined from a consolidator in the dentist market and was previously chief executive of logistics business Yodel.

Its ultimate parent company is Blixt Fund I LP, based in the Cayman Islands and the ultimate controlling party is Blixt boss Carl Harring.




Blog


Does the Lloyd review mark the end of the Legal Services Act?

The Legal Services Board often generates eye-rolls and irritation from the leaders of the frontline regulators it oversees and of the representative bodies attached to them.


A familiar story?

There is no doubt that the rising cost of clinical negligence claims deserves attention. However, the system’s true cost driver is often not the claim itself.


When AI becomes a line on the client’s bill

On 23 June, Legora changed how it charges. The platform announced that its most capable product was moving away from a flat per-seat licence fee to consumption-based pricing


Loading animation